Advanced Veterinary and Human-Grade Generic Medicines for the Brazilian Market
Since the enactment of the Generic Drugs Law in 1999, Brazil has witnessed a healthcare transformation. Today, the Brazilian pharmaceutical market is the largest in Latin America and the 6th largest globally. Generic medicines represent over 35% of the market share in terms of volume, providing an essential pillar for the "Sistema Único de Saúde" (SUS).
Factories in Brazil are heavily regulated by ANVISA (Agência Nacional de Vigilância Sanitária), ensuring that every generic drug meets rigorous bioequivalence and pharmaceutical equivalence standards. This regulatory landscape has fostered a competitive environment where quality and affordability coexist.
The "Complexo Industrial da Saúde" (Health Industrial Complex) in Brazil is a strategic sector for the government. With massive investments in biotechnology and local synthesis of Active Pharmaceutical Ingredients (APIs), the country is reducing its reliance on imports from India and China.
Market Value
Prescription Rate
Pioneering the Future of Pharmaceutical Synthesis
Modern factories are integrating Artificial Intelligence to predict molecular stability and optimize synthesis pathways, reducing the time-to-market for complex generics.
Brazil's pharmaceutical suppliers are moving towards "Green Chemistry," focusing on biodegradable waste and energy-efficient distillation processes.
Blockchain technology is being adopted for drug traceability, ensuring that generic drugs distributed from São Paulo to the Amazon are authentic and safe.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Adapting Global Standards to Brazilian Specificities
Brazil is a global powerhouse in livestock exports. The demand for high-quality generic antibiotics and anti-parasitics (like Ivermectin and Ceftiofur) is critical for maintaining the health of the world's largest commercial cattle herd. Our products are formulated to withstand the tropical climate challenges of the Brazilian hinterland.
Equipped for Precision and Scale
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
Explore our full range of synthetic chemical drugs and GMP standard pharmaceuticals
The next decade for Brazil’s generic drug suppliers involves a transition from simple small-molecule generics to complex biosimilars. As patents for major biological drugs expire, Brazilian factories are gearing up to produce affordable generic versions of monoclonal antibodies and other high-tech therapies.
Furthermore, the "Pharma 4.0" initiative in Brazil is pushing factories to adopt IoT (Internet of Things) sensors on production lines. This allows for real-time monitoring of temperature, pH, and humidity, which is vital for the stability of drug batches. For international suppliers like Hangzhou Jeci Biochem, this creates a fertile ground for collaboration in R&D and high-purity intermediate supply.
SJ medical
